Literature DB >> 10652444

Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro.

M P Flavin1, G Zhao, L T Ho.   

Abstract

Several CNS disorders feature microglial activation. Microglia are known to have both restorative and cytotoxic capabilities. Neuronal apoptosis has been noted after an acute insult such as ischemia. Microglia may participate in this event. We previously showed that conditioned medium (CM) harvested from peritoneal macrophages or from activated microglia triggered apoptosis in rat hippocampal neurons in culture. We wished to characterize the factor responsible for triggering neuronal death. Quiescent microglia produced CM that did not disrupt hippocampal neurons. Lipopolysaccharide-activated microglia produced CM which resulted in neuronal death. This effect was blocked by plasminogen activator inhibitor-1, by tPA STOP, and by co-incubation with tPA antibody. Recombinant human tPA exaggerated the neurotoxic effects of microglial CM, while tPA alone was toxic only at very high concentrations. This in vitro system, which probably excludes any significant impact of microglial free radicals, suggests that microglial tPA may contribute significantly to hippocampal neuronal death. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10652444

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  24 in total

1.  Morphine Withdrawal Increases Brain-Derived Neurotrophic Factor Precursor.

Authors:  Alessia Bachis; Lee A Campbell; Kierra Jenkins; Erin Wenzel; Italo Mocchetti
Journal:  Neurotox Res       Date:  2017-08-03       Impact factor: 3.911

Review 2.  Microglial functions and proteases.

Authors:  Hiroshi Nakanishi
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

3.  Inflammation and NFkappaB activation is decreased by hypothermia following global cerebral ischemia.

Authors:  Carla M Webster; Stephen Kelly; Maya A Koike; Valerie Y Chock; Rona G Giffard; Midori A Yenari
Journal:  Neurobiol Dis       Date:  2008-11-19       Impact factor: 5.996

4.  Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia.

Authors:  T Tikka; B L Fiebich; G Goldsteins; R Keinanen; J Koistinaho
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

5.  An inhibitor of serine proteases, neuroserpin, acts as a neuroprotective agent in a mouse model of neurodegenerative disease.

Authors:  Yannick Simonin; Yves Charron; Peter Sonderegger; Jean-Dominique Vassalli; Ann C Kato
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

6.  Combination Therapy Using tPA and Edaravone Improves the Neurotoxic Effect of tPA.

Authors:  T Kano; T Harada; T Hirayama; Y Katayama
Journal:  Interv Neuroradiol       Date:  2007-06-27       Impact factor: 1.610

Review 7.  Tissue-type plasminogen activator as a therapeutic target in stroke.

Authors:  Iordanis Gravanis; Stella E Tsirka
Journal:  Expert Opin Ther Targets       Date:  2008-02       Impact factor: 6.902

Review 8.  Plasminogen activator inhibitor-1: the double-edged sword in apoptosis.

Authors:  Rashna D Balsara; Victoria A Ploplis
Journal:  Thromb Haemost       Date:  2008-12       Impact factor: 5.249

9.  Plasminogen activator inhibitor-1 is increased in colonic epithelial cells from patients with colitis-associated cancer.

Authors:  Earl Gillespie; Susan E Leeman; Luisa A Watts; Jennifer A Coukos; Michael J O'Brien; Sandra R Cerda; Francis A Farraye; Arthur F Stucchi
Journal:  J Crohns Colitis       Date:  2012-08-23       Impact factor: 9.071

10.  Novel Combinatorial Therapeutic Targeting of PAI-1 (SERPINE1) Gene Expression in Alzheimer's Disease.

Authors:  Stacie M Kutz; Craig E Higgins; Paul J Higgins
Journal:  Mol Med Ther       Date:  2012-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.